Skip Navigation



NDT Advance Access published online on May 10, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh902
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/7/1516    most recent
gfh902v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Decupere, M.
Right arrow Articles by Claes, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Decupere, M.
Right arrow Articles by Claes, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Letter

Artifactual hypocalcaemia after intravenous administration of gadodiamide (Omniscan®)

Marc Decupere 1, Vanessa Ooms 1, Raymond Oyen 1, Dirk R. J. Kuypers 1, and Kathleen Claes 1*

1 Department of Nephrology and Renal Transplantation, University Hospitals, Leuven, Belgium

* To whom correspondence should be addressed.
Kathleen Claes, E-mail: Kathleen.Claes{at}uz.kuleuven.ac.be



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.